G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/53 (2006.01) C07K 16/28 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2323743
The present invention relates to the use of molecules capable of specifically binding a urokinase plasminogen activator receptor (uPAR) as diagnostic reagents for the detection of metastases in vivo. Such metastases can include, but are not limited to, micrometastases.
La présente invention se rapporte à l'utilisation de molécules pouvant se fixer spécifiquement au récepteur des activateurs du plasminogène de l'urokinase (uPAR) comme agents diagnostiques pour détecter des métastases in vivo. Ces métastases peuvent englober entre autres, des micrométastases.
Hart Richard
Rabbani Shafaat A.
Hart Richard
Pharmaip Llc
Rabbani Shafaat A.
Ridout & Maybee Llp
University Mcgill
LandOfFree
Urokinase plasminogen activator receptor as a target for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urokinase plasminogen activator receptor as a target for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urokinase plasminogen activator receptor as a target for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2078065